176 related articles for article (PubMed ID: 33984018)
1. Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.
Pranpanus S; Kor-Anantakul O; Suntharasaj T; Suwanrath C; Hanprasertpong T; Pruksanusak N; Petpichetchian C; Suksai M; Chainarong N; Sawaddisan R
PLoS One; 2021; 16(5):e0251381. PubMed ID: 33984018
[TBL] [Abstract][Full Text] [Related]
2. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
3. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
4. Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group.
Wanapirak C; Sirichotiyakul S; Luewan S; Yanase Y; Traisrisilp K; Tongsong T
J Obstet Gynaecol Res; 2012 Apr; 38(4):686-91. PubMed ID: 22380630
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand.
Kaewsuksai P; Jitsurong S
Int J Gynaecol Obstet; 2017 Nov; 139(2):217-221. PubMed ID: 28762499
[TBL] [Abstract][Full Text] [Related]
6. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of inhibin-A in second-trimester screening for Down syndrome.
Benn PA; Fang M; Egan JF; Horne D; Collins R
Obstet Gynecol; 2003 Mar; 101(3):451-4. PubMed ID: 12636947
[TBL] [Abstract][Full Text] [Related]
9. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
Hsu JJ; Hsieh TT; Hsieh FJ
Obstet Gynecol; 1996 Jun; 87(6):943-7. PubMed ID: 8649703
[TBL] [Abstract][Full Text] [Related]
11. Practical strategies in contingent sequential screening for Down syndrome.
Benn P; Wright D; Cuckle H
Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
[TBL] [Abstract][Full Text] [Related]
12. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
13. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
Cuckle HS; van Lith JM
Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
[TBL] [Abstract][Full Text] [Related]
14. Prospective prenatal serum screening for Down syndrome in Venezuela.
Alvarez-Nava F; Soto M; Morales-Machín A; Rojas A; Urdaneta K; Cañizález J
Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910
[TBL] [Abstract][Full Text] [Related]
15. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.
Xie Z; Lu S; Li H
Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750
[TBL] [Abstract][Full Text] [Related]
16. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
Wenstrom KD; Owen J; Chu Dc; Boots L
Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
[TBL] [Abstract][Full Text] [Related]
18. Median levels of serum biomarkers of fetal Down syndrome detected during the first trimester among pregnant Thai women.
Luewan S; Sirichotiyakul S; Yanase Y; Traisrisilp K; Tongsong T
Int J Gynaecol Obstet; 2012 May; 117(2):140-3. PubMed ID: 22365285
[TBL] [Abstract][Full Text] [Related]
19. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK
Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.
Wang YY; Luo J; Zhu MW; Liu LN; Ma X
Int J Gynaecol Obstet; 2006 Jul; 94(1):67-72. PubMed ID: 16806218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
